Placental growth factor and Fms related tyrosine kinase-1 are hypomethylated in preeclampsia placentae

Epigenomics. 2021 Feb;13(4):257-269. doi: 10.2217/epi-2020-0318. Epub 2021 Jan 20.

Abstract

Aim: This study aims to examine the DNA methylation (DNAm) and expression patterns of genes associated with placental angiogenesis in preeclampsia. Materials & methods: DNAm and expression were examined in normotensive (n = 100) and preeclampsia (n = 100) women using pyrosequencing and quantitative real-time PCR respectively. Results: Hypomethylation at several CpGs was observed in PlGF and FLT-1 in women with preeclampsia compared to normotensive controls. PlGF expression was lower in women with preeclampsia while FLT-1 expression was comparable. DNAm at various CpGs was negatively correlated with expression in both the genes and were associated with maternal blood pressure and birth outcomes. Conclusion: DNAm and expression of angiogenic factors in placentae are differentially regulated in preeclampsia and influence birth outcomes.

Keywords: DNA methylation; FLT-1; PlGF; birth outcome; mRNA expression; placenta; preeclampsia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Base Sequence
  • Case-Control Studies
  • DNA Methylation / physiology*
  • Female
  • Humans
  • Placenta / metabolism*
  • Placenta Growth Factor / metabolism*
  • Pre-Eclampsia / metabolism*
  • Pregnancy
  • Receptor, Macrophage Colony-Stimulating Factor / metabolism*
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism*
  • Young Adult

Substances

  • Placenta Growth Factor
  • FLT1 protein, human
  • Receptor, Macrophage Colony-Stimulating Factor
  • Vascular Endothelial Growth Factor Receptor-1